Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Doona, M.
Right arrow Articles by Walsh, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doona, M.
Right arrow Articles by Walsh, D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cold and Cough Medicines
*Cough
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Benzonatate for opioid-resistant cough in advanced cancer

Marie Doona

Palliative Care Programme (a World Health Organization Demonstration Project), Cleveland Clinic Foundation, Cleveland

Declan Walsh

Harry R Horvitz Center for Palliative Medicine, Cleveland Clinic Foundation, Cleveland

Chronic cough is a distressing symptom experienced by approximately 37% of patients with advanced cancer. Palliation of chronic nonproductive cough should always first address the underlying cause but in some patients chronic, nonproductive cough persists and antitussive agents are required. Opioids are the gold standard cough suppressants, of which codeine is the most widely used; patients with an opioid-resistant cough often prove to be a therapeutic challenge. We report three patients with an opioid-resistant cough who achieved symptomatic relief with the peripherally acting nonopioid drug benzonatate.

Key Words: antitussive agents • benzonatate • cough • lung neoplasms • palliative care

Palliative Medicine, Vol. 12, No. 1, 55-58 (1998)
DOI: 10.1191/026921698672930910
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 ChestHome page
P. A. Kvale, P. A. Selecky, and U. B. S. Prakash
Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 368S - 403S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. A. Kvale
Chronic Cough Due to Lung Tumors: ACCP Evidence-Based Clinical Practice Guidelines
Chest, January 1, 2006; 129(1_suppl): 147S - 153S.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M G Belvisi and P Geppetti
Cough * 7: Current and future drugs for the treatment of chronic cough
Thorax, May 1, 2004; 59(5): 438 - 440.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. A. Kvale, M. Simoff, and U. B. S. Prakash
Palliative Care
Chest, January 1, 2003; 123 (2009): 284S - 311S.
[Abstract] [Full Text] [PDF]

Home page
 AM J HOSP PALLIAT CAREHome page
J. Homsi, D. Walsh, K. A. Nelson, N. Sarhill, L. Rybicki, S. B. LeGrand, and M. P. Davis
A phase II study of hydrocodone for cough in advanced cancer
American Journal of Hospice and Palliative Medicine, January 1, 2002; 19(1): 49 - 56.
[Abstract] [PDF]